TPTh 8.04 Recurrence in colorectal cancer (CRC) resections: A Cohort Study
British Journal of Surgery · 05.08.2026 · 113 (Supplement_8)
DOI: 10.1093/bjs/znag087.506 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift British Journal of Surgery, online erschienen am 05.08.2026. Verfasst von K Riaz und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Aims
CRC-recurrence after CRC-resection is an adverse feature with reported-incidence: <30%, peak recurrence occurring <2-years & 95% recurrence occurring <5-years. CRC-recurrence will affect-QOL & prognosis. Aim-of-study is to assess surgical-outcomes in CRC-recurrence following-resections.
Methods
Cohort-study was carried-out-from: Jan’2007 to Jan’2026 at single institution. Descriptive-demographics, post-operative-outcomes were analysed in CRC-recurrence. All non recurrent CRC resections recruited-as-controls.
Results
Recurrence (n=388) Non recurrence (n=1609) Mann-Whitney-U-test (p-value) Age(yrs) 70.2±0.6 70.2±0.3 NS Sex(M:F) 214:174 874:735 NS BMI(kg/m2) 25.7±0.3 26.8±0.2 NS ASA(median) 2±0.5 2±0.5 NS Local-recurrence(n) 47 Liver-mets(n) 195 Lung-met (n) 174 Others(n) 188 90-D-deaths(n)(%) 20(6.9%) 101 NS Laparoscopy(n) 180(46.4%) 1031 <0.0001 LN-harvest(n) 16±6 18 ± 6 NS AN-involvement(n) 51 58 0.0082 Vascular-invasion(n) 170 389 <0.0001 CRM-involve(n) 90 102 <0.0001 Differentiation(n) Well 4 47 NS Well/moderate 6 71 NS Moderate 228 855 NS Moderate/poor 11 36 NS Poor 45 133 NS Others 94 467 Stage-1(n) 24 443 <0.0001 Stage-2(n) 99 545 0.0002 Stage-3(n) 208 468 <0.0001 Stage-4(n) 52 94 <0.0001 Others(n) 5 59 NS Survival-rates(%) 1st-year 77.4 86.1 Logrank-(p<0.0001)-(uncensored) 5th-year 21.0 72.9 15th-year 6.3 56.7 Conclusions CRC recurrence occurred in 19.4% of CRC-resections in-our-study. CRC-recurrence can be characterized as:-loco-regional,-liver,-lung &-others (e.g-bone,-brain) & depends on tumour-stage & differentiation. CRC-recurrence was-observed: AN-involvement, vascular-invasion & CRM-involvements. CRC-recurrence can be offered: curative re-resection & multi-modal therapy (chemotherapy, immunotherapy & radiotherapy). This study supports colorectal surveillance extending to 5-years (& longer in young patients).
Zitieren
APA
Riaz, K., Gok, M. A., Khan, S., Pogodina, A., Bughio, M., & Khan, U. A. (2026). TPTh 8.04 Recurrence in colorectal cancer (CRC) resections: A Cohort Study. British Journal of Surgery, 113(Supplement_8). https://doi.org/10.1093/bjs/znag087.506
Vancouver
Riaz K, Gok MA, Khan S, Pogodina A, Bughio M, Khan UA. TPTh 8.04 Recurrence in colorectal cancer (CRC) resections: A Cohort Study. British Journal of Surgery. 2026;113(Supplement_8). doi:10.1093/bjs/znag087.506
BibTeX
@article{Riaz2026,
author = {Riaz, K and Gok, M A and Khan, S and Pogodina, A and Bughio, M and Khan, U A},
title = {TPTh 8.04 Recurrence in colorectal cancer (CRC) resections: A Cohort Study},
journal = {British Journal of Surgery},
year = {2026},
volume = {113},
number = {Supplement_8},
doi = {10.1093/bjs/znag087.506}
}
EUVIMED